We are live on ! Find out more
HA

Hamel Associates Portfolio holdings

AUM $363M
1-Year Est. Return 24.39%
This Fund
S&P 500
This Quarter Est. Return
+2.64%
1 Year Est. Return
+24.39%
3 Year Est. Return
+50.64%
5 Year Est. Return
+68.03%
10 Year Est. Return
+174.56%
AUM
$294M
AUM Growth
-$16.5M
Cap. Flow
-$20.7M
Cap. Flow %
-7.03%
Top 10 Hldgs %
38.31%
Holding
75
New
1
Increased
14
Reduced
45
Closed
4

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$3.45M
2
HSY icon
Hershey
HSY
+$3.15M
3
SCHY icon
Schwab International Dividend Equity ETF
SCHY
+$2.74M
4
VZ icon
Verizon
VZ
+$1.51M
5
GLD icon
SPDR Gold Trust
GLD
+$1.18M

Sector Composition

Rank Sector Weight
1 Miscellaneous 16.98%
2 Consumer Staples 15.47%
3 Healthcare 12.02%
4 Technology 11.14%
5 Energy 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.84T
$16.8M 5.69%
75,415
-2,022
-3% -$468K
WMT icon
2
Walmart Inc
WMT
$858B
$14.6M 4.95%
165,748
-37,480
-18% -$3.52M
XOM icon
3
ExxonMobil
XOM
$696B
$12.3M 4.18%
103,401
-2,733
-3% -$302K
CB icon
4
Chubb
CB
$132B
$11.5M 3.93%
38,243
-440
-1% -$122K
JNJ icon
5
Johnson & Johnson
JNJ
$644B
$11.1M 3.76%
66,719
-160
-0.2% -$25K
COP icon
6
ConocoPhillips
COP
$170B
$9.95M 3.38%
94,715
+1,190
+1% +$119K
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.18T
$9.87M 3.35%
63,172
-985
-2% -$180K
PG icon
8
Procter & Gamble
PG
$341B
$9.75M 3.31%
57,207
-8,605
-13% -$1.44M
MSFT icon
9
Microsoft
MSFT
$3.69T
$9.04M 3.07%
24,079
-670
-3% -$273K
CVX icon
10
Chevron
CVX
$427B
$7.91M 2.69%
47,286
-195
-0.4% -$30.5K
BNY
11
Bank of New York Mellon
BNY
$105B
$7.85M 2.67%
93,620
-4,370
-4% -$367K
MRK icon
12
Merck
MRK
$355B
$7.72M 2.62%
85,971
-2,233
-3% -$208K
ITW icon
13
Illinois Tool Works
ITW
$76.5B
$7.33M 2.49%
29,570
-375
-1% -$96.4K
KO icon
14
Coca-Cola
KO
$382B
$7M 2.38%
97,783
-440
-0.4% -$29.4K
MCD icon
15
McDonald's
MCD
$179B
$6.85M 2.33%
21,929
-208
-0.9% -$62.2K
IBDS icon
16
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.92B
$6.38M 2.17%
264,018
-74,937
-22% -$1.8M
UNP icon
17
Union Pacific
UNP
$169B
$6.25M 2.13%
26,468
-368
-1% -$88.6K
IBDR icon
18
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.25B
$6.11M 2.08%
252,444
-69,896
-22% -$1.69M
IBDT icon
19
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.08B
$5.99M 2.03%
236,985
-69,750
-23% -$1.75M
IBDQ
20
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$5.92M 2.01%
235,283
-65,644
-22% -$1.65M
HON icon
21
Honeywell
HON
$64.5B
$5.63M 1.91%
28,199
+286
+1% +$57.9K
AMGN icon
22
Amgen
AMGN
$203B
$5.54M 1.88%
17,771
+1,025
+6% +$303K
JPM icon
23
JPMorgan Chase
JPM
$937B
$5.4M 1.84%
22,027
-5,220
-19% -$1.33M
ED icon
24
Consolidated Edison
ED
$38.9B
$5.36M 1.82%
48,487
+8,247
+20% +$809K
GLD icon
25
SPDR Gold Trust
GLD
$145B
$5.09M 1.73%
17,658
+4,468
+34% +$1.18M

Similar funds

Hamel Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Hamel Associates held 75 positions worth $294M, down 5.3% from $311M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Hamel Associates withdrew a net $20.7M in Q1 2025, closing 4 positions and reducing 45 holdings. Its most notable exit was Brown-Forman Class B, an estimated $2.34M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 17% of assets, down from 20% a quarter earlier, followed by Consumer Staples and Healthcare.

Against the trend, Hamel Associates opened a new position in Bristol-Myers Squibb worth $220K.

  • Hamel Associates's largest Q1 2025 buy was Bristol-Myers Squibb: 3,602 shares worth $220K.
  • Hamel Associates added most to Novartis in Q1 2025, an estimated $3.45M increase.
  • Hamel Associates's biggest Q1 2025 reduction was iShares Treasury Floating Rate Bond ETF, cutting an estimated $4.37M.
  • Hamel Associates fully exited Brown-Forman Class B in Q1 2025, selling an estimated $2.34M.
  • Hamel Associates's ten largest holdings make up 38% of its $294M portfolio in Q1 2025.
  • Hamel Associates opened 1 new position and closed 4 in Q1 2025.
  • Hamel Associates's portfolio value fell 5.3% quarter-over-quarter to $294M.

Based on Hamel Associates's 13F filing for Q1 2025, filed 6 May 2025.